Holders · period archive

DMAC · Diamedica Therapeutics Inc.

Q2 2022 13F holders among managers we track latest ownership dossier

Ticker: DMAC
Type: Equity
Class: COM
Total reported value ($000, long equity)

Manager	Report date	Value	Shares